moi Corp.

Moi announced that, as a result of joint research with the Center for iPS Cell Research and Application at Kyoto University, it has completed a joint patent filing with Kyoto University for technology that links neural spheroids and brain organoids created from iPS cells with large language models. The announcement drew market attention, and buy orders flooded in from the morning, putting the stock at its daily limit with a buy-side quote. Through this joint research, the company plans to proceed with prototype development of a biologically linked AI dialogue system and to advance research and development toward social implementation and commercialization of the technology. The company has suddenly come into the spotlight as an AI-related stock.

Among companies that reported earnings after the close on September 10, several were singled out as likely to win market praise for strong results or dividend increases. Aruplan raised its consolidated ordinary profit forecast for the fiscal year ending January 2027 by 24.1%, from 3.77 billion yen to 4.68 billion yen, expanding its profit growth rate from 7.0% to 32.8% and adding to what would be a third straight year of record profit. The revision reflects brisk sales and orders for built-for-sale housing as well as improved profit margins from higher selling prices. The company also raised its annual dividend to 55 yen from the previously planned 45 yen. Oomori Kogyo lifted its consolidated ordinary profit forecast for the fiscal year ending July 2026 by 10.5%, from 680 million yen to 750 million yen, narrowing its expected profit decline from 9.9% to 0.4%. Moi said its first-half net profit for the fiscal year ending January 2027 grew 77.9% year on year to 12.1 million yen, and that it had completed a joint patent application based on joint research with Kyoto University's Center for iPS Cell Research and Application.